Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry

被引:17
|
作者
Snyder, Laurie D. [1 ,2 ]
Mosher, Christopher [2 ]
Holtze, Colin H. [3 ]
Lancaster, Lisa H. [4 ]
Flaherty, Kevin R. [3 ]
Noth, Imre [5 ]
Neely, Megan L. [1 ,2 ]
Hellkamp, Anne S. [1 ,2 ]
Bender, Shaun [6 ]
Conoscenti, Craig S. [6 ]
de Andrade, Joao A.
Whelan, Timothy P. M. [7 ]
机构
[1] Duke Clin Res Inst, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Durham, NC 27708 USA
[3] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] Univ Virginia, Charlottesville, VA USA
[6] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[7] Med Univ South Carolina, Charleston, SC 29425 USA
关键词
interstitial fibrosis; CLINICAL-PRACTICE; SURVIVAL;
D O I
10.1136/bmjresp-2020-000567
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality. Patient characteristics associated with diagnostic delays are not well described. Methods Subjects who had not been diagnosed with IPF prior to referral and received a new diagnosis of IPF at an enrolling centre for the IPF-PRO (Idiopathic Pulmonary Fibrosis Prospective Outcomes) Registry were characterised as having a longer (>1 year) or shorter (<= 1 year) time from symptom onset to diagnosis and from first imaging evidence of fibrosis to diagnosis. Patient characteristics, evaluations and time to death or lung transplant were compared between these cohorts. Result sAmong 347 patients with a symptom onset date, 49% were diagnosed with IPF >1 year after symptom onset. These patients were slightly younger and had more cardiac comorbidities than patients diagnosed <= 1 year after symptom onset. Among 454 patients with a date for imaging evidence of fibrosis, 78% were diagnosed with IPF <= 1 year later. A greater proportion of patients with >1 year versus <= 1 year from imaging evidence of fibrosis to diagnosis had cardiac comorbidities and gastro-oesophageal reflux. There was no significant difference in time to death or lung transplant between groups by time to diagnosis. Conclusions The time from symptom onset to diagnosis remains over 1 year in approximately half of the patients with IPF, but once imaging evidence is obtained, most of the patients are diagnosed within a year. Cardiac conditions and gastro-oesophageal disorders were more commonly reported in patients with a longer time to diagnosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Time to Diagnosis of Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry
    Snyder, L. D.
    Mosher, C.
    Holtze, C. H.
    Lancaster, L. H.
    Flaherty, K. R.
    Noth, I.
    Neely, M. L.
    Hellkamp, A. S.
    Bender, S.
    Conoscenti, C. S.
    De Andrade, J. A.
    Whelan, T. P. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [2] Time From First Imaging Showing Pulmonary Fibrosis to Diagnosis of Idiopathic Pulmonary Fibrosis: Data From the IPF-PRO Registry
    Deandrade, Joao
    Conoscenti, Craig
    Flaherty, Kevin
    Holtze, Colin
    Lancaster, Lisa
    Neely, Megan
    Snyder, Laurie
    Yow, Eric
    Whelan, Timothy
    [J]. CHEST, 2017, 152 (04) : 445A - 445A
  • [3] Survival in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry
    Palmer, S. M.
    Snyder, L.
    Neely, M. L.
    Yow, E.
    Bender, S.
    Culver, D. A.
    de Andrade, J.
    Gulati, M.
    Kaner, R. J.
    Leonard, T.
    O'Brien, E.
    Pushlar, N.
    Conoscenti, C. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] HOSPITALIZATIONS AND OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): INSIGHTS FROM THE IPF-PRO REGISTRY
    Kim, Hyun
    Neely, Megan
    Janssen, Katherine
    Adegunsoye, Ayodeji
    Strek, Mary
    Yow, Eric
    Conoscenti, Craig
    Leonard, Thomas
    Snyder, Laurie
    [J]. CHEST, 2020, 158 (04) : 1062A - 1063A
  • [5] Predictors of death or transplant in patients with idiopathic pulmonary fibrosis in the IPF-PRO Registry
    Snyder, Laurie
    Neely, Megan L.
    Hellkamp, Anne
    O'Brien, Emily
    Flaherty, Kevin R.
    De Andrade, Joao
    Conoscenti, Craig
    Leonard, Thomas
    Bender, Shaun
    Gulati, Mridu
    Culver, Daniel A.
    Kaner, Robert J.
    Palmer, Scott
    Kim, Hyun J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN THE US: DATA FROM THE IPF-PRO REGISTRY
    Culver, Daniel
    Yow, Eric
    Neely, Megan
    Belperio, John
    Bender, Shaun
    De Andrade, Joao
    Roman, Jesse
    Whelan, Timothy
    Palmer, Scott
    Conoscenti, Craig
    [J]. CHEST, 2018, 154 (04) : 397A - 398A
  • [7] Treatment Patterns in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry
    Salisbury, M. L.
    Conoscenti, C. S.
    Culver, D. A.
    Yow, E.
    Neely, M.
    Bender, S.
    Hartmann, N.
    Palmer, S.
    Leonard, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [8] OUTCOMES OF PATIENTS WITH COMBINED IDIOPATHIC PULMONARY FIBROSIS AND EMPHYSEMA IN THE IPF-PRO REGISTRY
    Kim, Hyun
    Snyder, Laurie
    Neely, Megan
    Hellkamp, Anne
    Hotchkin, David
    Morrison, Lake
    Bender, Shaun
    Leonard, Thomas
    Culver, Daniel
    [J]. CHEST, 2020, 158 (04) : 2440A - 2441A
  • [9] Prevalence Of Pulmonary Hypertension In Newly Diagnosed Patients With Idiopathic Pulmonary Fibrosis (ipf) Enrolled In The Ipf-Pro Registry
    Sheth, J. S.
    Belloli, E.
    Salisbury, M.
    Holtze, C. H.
    Yow, E.
    Neely, M. L.
    Conoscenti, C. S.
    White, E. S.
    Flaherty, K. R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [10] BASELINE CHARACTERISTICS OF PATIENTS IN THE IDIOPATHIC PULMONARY FIBROSIS PROSPECTIVE OUTCOMES (IPF-PRO) REGISTRY
    Culver, Daniel
    Yow, Eric
    Neely, Megan
    Bender, Shaun
    Dilling, Daniel
    Oldham, Justin
    Palmer, Scott
    Conoscenti, Craig
    [J]. CHEST, 2020, 158 (04) : 1040A - 1041A